_____________________________________________________________________________________________________________________
© 2005-7  All Rights Reserved. NOD Pharmaceuticals, Inc.
Business Focus
NOD Pharmaceuticals is an innovative biotechnology company focusing on oral delivery of
macromolecular drugs.  Nano-particle oral delivery or NOD technology is the core technology under
development.  You can find relevant information on NOD technology and products being developed
from the following pages:
NOD technology
Pipeline
Focus on Biopharmaceutical Delivery
NOD
Pharmaceuticals, Inc.
Delivers Innovation
What’s New?
IND for Nodlin, the leading oral insulin formulation developed with NOD technology, has been filed
with SFDA in China.  For news release, click here.
April 19, 2006  IND for Nodlin filed in China
Complete information on News and Events can be found on News page.
NOD Pharmaceuticals closed the series B financing of US$5.5 million.  For news release, click here.
December 30, 2006  NOD Pharmaceuticals, Inc. Closes Series B Financing